For dozens of millions of Americans suffering from different forms of arthritis, the stiffness, pain and other symptoms associated with this condition can be very stubborn. To compound matters, all the current medications offered only alleviate the symptoms with varying degrees of success and there is no cure. Many arthritis patients have therefore started picking interest in using cannabidiol (CBD) to manage their arthritis symptoms. But, is this a worthwhile undertaking?
Dr. Peter Grinspoon, a Massachusetts General Hospital primary care physician, says that most of the research on CBD are animal studies that largely focused on investigating the effects of…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor